Status:
COMPLETED
Effects of Degludec/Liraglutide on Time in Range, Inflammation and Endothelial Function vs Insulin Basal Bolus in Diabetic Inpatients
Lead Sponsor:
University of Palermo
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
The study aims to evaluate the effects of Insulin Degludec/Liraglutide on glycemic variability assessed by continuous glycemic monitoring with the function time in range, serum markers of inflammation...
Detailed Description
100 patients with type 2 diabetes mellitus were recruited at the Internal Medicine with Stroke care ward of the University hospital of Palermo "P. Giaccone" from April 2022 to April 2024. 50 patients ...
Eligibility Criteria
Inclusion
- Diabetes mellitus type 2
- Mild-moderate Hyperglycemia (180-400 mg/dl)
- Acute events (Pneumonia, Acute cardiac Ischemia, Ictus, IVU)
Exclusion
- Diabetes mellitus type 1
- Diabetic ketoacidosis
- Hyperosmolar coma
- Severe hypoglycaemia
- Acute Pancreatitis
- Cancer
- use of corticosteroids
- pregnancy
- Chronic kidney disease (\< 30 ml/min) or hemodialysis
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 20 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05360537
Start Date
April 1 2021
End Date
April 20 2022
Last Update
December 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Internal Medicine Ward, University of Palermo
Palermo, Italy, 90127